Biofrontera AG Sponsored ADR Non-operating Income/Expense

Non-operating Income/Expense of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-operating Income/Expense growth rates and interactive chart. Income or expense that is usually non-recurring and not tied to a company's operations. It is stated separately on the income statement to differentiate it from operating expenses.


Highlights and Quick Summary

  • Non-operating Income/Expense for the quarter ending June 30, 2022 was $-210 Thousand (a -99.36% decrease compared to previous quarter)
  • Year-over-year quarterly Non-operating Income/Expense decreased by -77.75%
  • Annual Non-operating Income/Expense for 2021 was $84 Million (a 13.44% increase from previous year)
  • Annual Non-operating Income/Expense for 2021 was $74.1 Million (a -1374.5% decrease from previous year)
  • Annual Non-operating Income/Expense for 2020 was $-5.81 Million (a 1143.43% increase from previous year)
  • Twelve month Non-operating Income/Expense ending June 30, 2022 was $31.4 Million (a -0.93% decrease compared to previous quarter)
  • Twelve month trailing Non-operating Income/Expense decreased by -1206.42% year-over-year
Trailing Non-operating Income/Expense for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$31.4 Million $31.7 Million $63.6 Million $-2.84 Million
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-operating Income/Expense of Biofrontera AG Sponsored ADR

Most recent Non-operating Income/Expenseof BFAGY including historical data for past 10 years.

Interactive Chart of Non-operating Income/Expense of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.21 $-32.83
2021 $65.41 $-0.95 $0.09 $-0.95 $84.03
2020 $-1.03 $-2.76 $-1.39 $1.18 $-5.81
2019 $0.11 $-3.69 $0.15 $20.83
2018 $-0.51 $-0.93
2017 $-0.77 $-0.25 $-2.45
2016 $1.33

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic